Toward the Global Control of Human Scabies: Introducing the International Alliance for the Control of Scabies

PLoS Neglected Tropical Diseases

Volumn 7, Issue 8, 2013, Pages

  Engelman, Daniel ^a   Kiang, Karen ^a   Chosidow, Olivier ^b   McCarthy, James ^c   Fuller, Claire ^d   Lammie, Patrick ^e   Hay, Roderick ^f   Steer, Andrew ^a,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HENRI MONDOR HOSPITAL   (France)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f International Foundation for Dermatology   (United Kingdom)

^g MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; MOXIDECTIN; PERMETHRIN;

ARTICLE; AWARENESS; CHRONIC KIDNEY DISEASE; CROWDING (AREA); DISEASE ASSOCIATION; DISEASE CONTROL; GENETICS; HEALTH PROGRAM; HUMAN; IMPETIGO; INFECTION CONTROL; INFECTION RISK; INTERNATIONAL ALLIANCE FOR THE CONTROL OF SCABIES; KIDNEY FAILURE; MORBIDITY; MORTALITY; NONHUMAN; ONCHOCERCIASIS; POVERTY; PUBLIC HEALTH; SCABIES;

EID: 84883385809     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002167     Document Type: Article

References (32)

1. World Health Organization (2005) Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organization.
2. Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ, (1997) Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 16: 494-499.
3. Currie BJ, Connors CM, Krause VL, (1994) Scabies programs in aboriginal communities. Med J Aust 161: 636-637.
4. Hay RJ, Steer AC, Engelman D, Walton S, (2012) Scabies in the developing world-its prevalence, complications, and management. Clin Microbiol Infect 18: 313-323.
5. Jackson A, Heukelbach J, Filho AF, Junior Ede B, Feldmeier H, (2007) Clinical features and associated morbidity of scabies in a rural community in Alagoas, Brazil. Trop Med Int Health 12: 493-502.
6. Roberts LJ, Huffam SE, Walton SF, Currie BJ, (2005) Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 50: 375-381.
7. Engels D, Savioli L, (2006) Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol 22: 363-366.
8. Feldmeier H, (2009) Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Organ 87: 152-159.
9. Mika A, Reynolds SL, Pickering D, McMillan D, Sriprakash KS, et al. (2012) Complement inhibitors from scabies mites promote streptococcal growth - a novel mechanism in infected epidermis? PLoS Negl Trop Dis 6: e1563 doi:10.1371/journal.pntd.0001563.
10. Carapetis JR, Steer AC, Mulholland EK, Weber M, (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694.
11. Berrios X, Lagomarsino E, Solar E, Sandoval G, Guzman B, et al. (2004) Post-streptococcal acute glomerulonephritis in Chile-20 years of experience. Pediatr Nephrol 19: 306-312.
12. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, et al. (2005) Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 83: 34-42.
13. Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, et al. (2012) Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int 81: 1026-1032.
14. Parks T, Smeesters PR, Steer AC, (2012) Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis 25: 145-153.
15. Hay RJ, Estrada Castanon R, Alarcon Hernandez H, Chavez Lopez G, Lopez Fuentes LF, et al. (1994) Wastage of family income on skin disease in Mexico. BMJ 309: 848.
16. Verma BL, Srivastava RN, (1990) Measurement of the personal cost of illness due to some major water-related diseases in an Indian rural population. Int J Epidemiol 19: 169-176.
17. Strong M, Johnstone P, (2007) Interventions for treating scabies. Cochrane Database Syst Rev pp. CD000320.
18. Currie BJ, McCarthy JS, (2010) Permethrin and ivermectin for scabies. New Engl J Med 362: 717-725.
19. La Vincente S, Kearns T, Connors C, Cameron S, Carapetis J, et al. (2009) Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl Trop Dis 3: e444 doi:10.1371/journal.pntd.0000444.
20. World Health Organization (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: World Health Organization.
21. World Health Organization (2012) Global report for research on infectious diseases of poverty. Geneva: World Health Organization, on behalf of the Special Programme for Research and training in Tropical Disease.
22. World Health Organization (2012) Neglected tropical diseases: diseases covered by NTD department. Available: http://www.who.int/neglected_diseases/diseases/en/. Accessed 11 December 2012.
23. Steer AC, Tikoduadua LV, Manalac EM, Colquhoun S, Carapetis JR, et al. (2009) Validation of an Integrated Management of Childhood Illness algorithm for managing common skin conditions in Fiji. Bull World Health Organ 87: 173-179.
24. Mahe A, Faye O, N'Diaye HT, Ly F, Konare H, et al. (2005) Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg 99: 39-47.
25. Taplin D, Meinking TL, Chen JA, Sanchez R, (1990) Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 7: 67-73.
26. Wong LC, Amega B, Connors C, Barker R, Dulla ME, et al. (2001) Outcome of an interventional program for scabies in an Indigenous community. Med J Aust 175: 367-370.
27. Andrews RM, Kearns T, Connors C, Parker C, Carville K, et al. (2009) A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis 3: e554 doi:10.1371/journal.pntd.0000554.
28. Fox LM, (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 19: 588-593.
29. Ottesen EA, Hooper PJ, Bradley M, Biswas G, (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2: e317 doi:10.1371/journal.pntd.0000317.
30. Currie BJ, Harumal P, McKinnon M, Walton SF, (2004) First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 39: e8-12.
31. Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF, (2008) Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 3: 57-66.
32. Alasaad S, Walton S, Rossi L, Bornstein S, Abu-Madi M, et al. (2011) Sarcoptes-World Molecular Network (Sarcoptes-WMN): integrating research on scabies. Int J Infect Dis 15: e294-297.